Home > NRC Library > ADAMS Public Documents

Forwards documents comprising regulatory history of rev to 10CFR35 (SECY-84-485),published for comment on 850726.

Accession Number: ML20136D915

Date Released: Monday, October 28, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20137Q519 - Forwards documents comprising regulatory history of rev to 10CFR35 (SECY-84-485),published for comment on 850726. (5 page(s), 9/6/1985)
• ML20137R520 - Clarifies Region III position re proposed rev to 10CFR35. Publication after modifying Section 35.36 to require that applicants & licensees submit changes to radiation safety program which decrease effectiveness preferred. (1 page(s), 10/29/1984)
• ML20137Q989 - Requests opportunity to make presentation before Commission on 830419 on proposed rev to 10CFR35 re physician use of radioactive drugs. (1 page(s), 3/31/1983)
• ML20137Q896 - Comments on draft 10CFR35 & draft rev to Reg Guide 10.8 re preparation of applications for medical programs. Uniformity needed between rule & reg guide.Retention period of 2 yrs for records not adequate for insp. (9 page(s), 4/6/1984)
• ML20137Q877 - Suggests briefing be development emphasizing listed points re proposed rev to 10CFR35.Comments encl. (5 page(s), 11/30/1984)
• ML20136E278 - Comments on proposed rev of 10CFR35.Recommends description of rulemaking applicability to all medical licensees. Requirement to perform wipe surveys & contamination limits should be added. (3 page(s), 9/2/1982)
• ML20137Q970 - Comments on staff paper re proposed rev to 10CFR35.NMSS should prepare summary of Agreement States positions accepted or rejected & related rationale for transmittal to Agreement States when proposal published for comment. (3 page(s), 1/14/1983)
• ML20137Q915 - Comments on proposed rev to 10CFR35 re human uses of byproduct matls.Need to focus resources on important safety issues & improve QC in licensing process records mgt & paper flow. (1 page(s), 6/4/1982)
• ML20137Q981 - Comments on proposed rev to 10CFR35.Rev supported.Agruments re savings & NRC resources overstated.Detailed evaluation of weakness in justification encl.Benefits to applicant appear valid. (4 page(s), 6/7/1982)
• ML20137R341 - Submits progress rept on 10CFR35,per 831220 request.Package distributed for concurrence on 840713.Concurrences due on 840737.Ofc of Administration & Region V concurred. (1 page(s), 8/7/1984)
• ML20137Q715 - Comments on proposed rev to 10CFR35.Lack of explanation of change in practice from preevaluation to post-evaluation of licensees cited.Analysis of impact on small entities warranted. (6 page(s), 6/18/1982)
• ML20137Q783 - Discusses draft statement of considerations on revised 10CFR35.District of Columbia Circuit Court decision in Connecticut Light & Power vs NRC summarized.Technical basis for major features of proposed 10CFR35 should be provided. (2 page(s), 4/21/1982)
• ML20137R256 - Requests analysis of significance & impact of changes to proposed rule 10CFR35 requiring prereview of physician qualifications & operating procedures suggested by DelMedico & Vacca. (1 page(s), 5/5/1983)
• ML20137Q902 - Forwards proposed rev to 10CFR35 & briefing handout.All recipient comments addressed.Ofc of State Programs & Region III concurrence reflected.All NRC ofcs now in concurrence w/proposed rev.W/o encl. (1 page(s), 12/17/1984)
• ML20137Q579 - Marked-up draft Commission paper recommending approval of notice of proposed rev to 10CFR35, "Medical Use of Byproduct Matl." Handwritten notes re document transmittal encl. (228 page(s), 10/15/1984)
• ML20137R624 - Forwards draft independent review package & voting sheets of RES Independent Review Board members.Members voted 4 to 0 that NRC should proceed w/"Human Uses of Byproduct Matls - Revs to 10CFR35," sponsored by NMSS. (2 page(s), 7/27/1984)
• ML20137Q682 - Comments on proposed rev to 10CFR35 re human use of byproduct matl.More standardized method for medical licensing supported.Early insp should be stressed as key safety feature of regulatory program. (6 page(s), 6/14/1982)
• ML20137R196 - Comments on proposed rule 10CFR35.NRC requirements should be placed on institution that holds license,not named individuals or positions in licensee organization.Detailed explanations encl. (9 page(s), 9/1/1982)
• ML20137Q953 - Comments on proposed rev to 10CFR35.Impact of proposal on existing medical general licensees needs amplification.Staff paper should be written to include listed items.Specific comments encl. (6 page(s), 11/5/1982)
• ML20137Q935 - Provides comments from four regions re revs to 10CFR35. Disagree that licensees will interpret linens,eating utensils & other items as radwaste. (2 page(s), 1/20/1984)
• ML20137R460 - Comments on proposed rev to 10CFR35.Converted licenses would be subj to amend & renewal fees specified in 10CFR170.31. (3 page(s), 7/27/1984)
• ML20137R479 - Concurs in issuance of proposed rev to 10CFR35,per 850713 request for review. (1 page(s), 8/2/1984)
• ML20137R609 - Recommends that rulemaking effort entitled, "Human Uses of Byproduct Matls - Revs to 10CFR35," continue.Reasons listed. RES independent review package includes some suggested word changes. (1 page(s), 8/30/1984)
• ML20137R375 - Forwards,for comment,draft proposed revs to 10CFR35 & Reg Guide 10.8 for preparation of applications for medical programs,per Chilk 830623 memo.Response requested by 840330. W/o encl. (2 page(s), 2/13/1984)
• ML20137R796 - Notifies that MT Lesar will represent Ofc of Administration on 10CFR35 task force. (1 page(s), 9/8/1983)
• ML20137Q585 - Recommends that Commission approve publication of notice of proposed rulemaking on 10CFR35, "Medical Use of Byproduct Matl." Press release discussing NRC proposal to simplify medical licensing procedures & FR notice encl. (328 page(s), 12/31/1984)
• ML20137R498 - Expresses reservations re proposed rev to 10CFR35.New concept re inspectors performing quality inps will cost more in time & money.State of GA prelicensing review working fine & considered necessary. (2 page(s), 8/2/1984)
• ML20137R215 - Positive ballot re SECY-84-485, "Proposed Rev of 10CFR35, `Medical Use of Byproduct Matl'." Comments encl. (2 page(s), 4/24/1985)
• ML20137Q650 - Comments on proposed amend to 10CFR35.Protective restrictions on use of Tc-99m labeled pentatate sodiums for lung function studies should not be removed. (1 page(s), 6/10/1982)
• ML20137R402 - Comments on proposed rev to 10CFR35 re human use of byproduct matl.Cost data used for present fee schedule for FY77 & out of date. (2 page(s), 9/16/1982)
• ML20137R900 - Confirms info re number of beds for NRC medical licensees, per survey. (4 page(s), 3/26/1985)
• ML20137R752 - Advises of Commission decisions re proposed changes to 10CFR35 (SECY-83-62).Consolidation of essential safety elements from regulations,guides & branch positions into 10CFR35 rule approved. (1 page(s), 6/23/1983)
• ML20137R209 - Provides dissenting prof opinion re proposed rev to 10CFR35 (SECY-83-62).NRC should not stop reviewing safety procedures in order to correct inefficiencies in typing, filing & other clerical functions. (4 page(s), 2/28/1983)
• ML20137R860 - Lists concerns expressed at Agreement States annual meeting. States request that adequate notice of presentation of 10CFR35 to Commission be provided in order that Agreement States be represented.Intention to draft alternative cited. (6 page(s), 10/25/1984)
• ML20137Q660 - Responds to 820308 memo re regulatory improvememt in matl licensing.JH Joyner & J Glenn will attend 820325 briefing in Silver Spring,MD.Draft rev to 10CFR35 dtd 820226 under review. (1 page(s), 3/18/1982)
• ML20137R395 - Forwards draft independent review package of rev to 10CFR35, "Human Uses of Byproduct Matl," per 840608 request.NRC should proceed w/specific ongoing rulemaking. (7 page(s), 6/22/1984)
• ML20137R472 - Concurs w/FR publication of proposed rev to 10CFR35 for comment.Minor suggestions for changes submitted by telcon. (1 page(s), 8/1/1984)
• ML20137R432 - Offers no recommendations for change to proposed rev to 10CFR35. (1 page(s), 7/27/1984)
• ML20137Q815 - Comments on draft position paper on rev to 10CFR35 re human use of byproduct matl.Changing patient release criteria to exposure rate of 5 milliroentgens/h at 1 meter may result in addl day of hospitalization for thyroid cancer patients. (1 page(s), 5/15/1982)
• ML20137Q596 - Package of FR reprints re NRC regulation of byproduct matl or medical use.HEW 750725 rept entitled, "Radioactive Drugs & Radioactive Biological Products" encl. (210 page(s), 9/6/1985)
• ML20136D909 - Reg Guide 10.8,Revision 1, "Guide for Preparation of Applications for Medical Programs." (60 page(s), 10/31/1980)
• ML20137R806 - Notifies that J Glenn will serve as contact w/task force revising 10CFR335,per 830826 memo. (1 page(s), 9/12/1983)
• ML20137Q655 - Summary of comments on proposed rev to 10CFR35,distributed for comment on 840213. (42 page(s), 9/6/1985)
• ML20137R738 - Requests copyright holder permission to place "Protocol for Determination of Absorbed Dose From High-Energy Photon & Electron Beams" in PDR.Proposed rev to 10CFR35 would allow licensees to use procedure. (1 page(s), 7/23/1984)
• ML20137R334 - Forwards proposed rev to 10CFR35, "Human Use of Byproduct Matl" & proposals for streamlining medical licensing process.Proposed rule should reduce paper work,decrease backlog & support regionalization.W/o encl. (4 page(s), 1/11/1983)
• ML20137R716 - Discusses Ofc of State Programs & Region III objections to proposed rev to 10CFR35, "Human Uses of Byproduct Matls." Most licensees do not have expertise to make adequate health & safety review of changes. (2 page(s), 10/15/1984)
• ML20137R095 - Ack receipt of revised 10CFR35 scehdule.Monthly repts on progress & status of each milestone required.First rept due on 840105. (1 page(s), 12/20/1983)
• ML20137R745 - Forwards matls sent to regions,for comment,re human use of licensed matl. (16 page(s), 12/29/1983)
• ML20137R913 - Comments on latest rev of proposed rule 10CFR35.Concerns restated.BJ Garcia 850220 ltr re State of AL & State of NM comments on proposed changes to 10CFR35 encl. (3 page(s), 2/26/1985)
• ML20137R240 - Positive ballot re SECY-84-485, "Proposed Rev of 10CFR35, `Medical Use of Byproduct Matl'." (1 page(s), 4/5/1985)
• ML20137Q889 - Discusses proposed rev to 10CFR35.Statement re reduction in regulatory & administrative burden on industry & use of automated mgt info sys as justification for rule change questioned. (1 page(s), 6/2/1982)
• ML20137Q692 - Comments on proposed rev to 10CFR35.Rev significant advance in recodification of diverse requirements in medical area. (2 page(s), 6/17/1982)
• ML20137R838 - Advises that significant problems found w/proposed Alternative 2 re rev to 10CFR35.Prelicensing review of radiation safety procedures & changes necessary to ensure proper degree of safety.Opportunity to testify requested. (1 page(s), 11/26/1984)
• ML20137R769 - Comments on draft proposed rev to 10CFR35.Alternative 2 flawed & unacceptable.Proposed rev to 10CFR35 as specified in Alternative 3 should be published for public comment. (2 page(s), 8/16/1984)
• ML20137R702 - Recommends approval of continued activity on listed rulemakings,included "Human Uses of Byproduct Matls - Revs to 10CFR35," per 840213 memo.Review packages encl. (11 page(s), 5/9/1984)
• ML20137R059 - Recommends that div work on amend to 10CFR35 be postponed until after Apr 1984 due to insufficient amount of personnel to complete project.Available resources & commitments will be reviewed in Apr to determine if revs feasible. (2 page(s), 9/21/1983)
• ML20137Q572 - Forwards draft proposed rev to 10CFR35, "Human Use of Byproduct Matl," retitled "Medical Use of Byproduct Matl" for public comment.Most Agreement States & some NRC staff disagree w/proposed licensing sys. (217 page(s), 7/13/1984)
• ML20137R118 - Forwards Rev 2 to Task 810892 work sheet.Delays in completing initial phases caused by significant expansion in scope,new regulatory requirements & inclusion of regional representatives to task force. (10 page(s), 5/20/1982)
• ML20136F109 - Submits comments discussed during 840723 telcon re proposed rev to 10CFR35, "Medical Use of Byproduct Matl." (2 page(s), 8/3/1984)
• ML20137R080 - Responds to 850329 memo forwarding Commission request for addl info re rev to 10CFR35, "Medical Use of Byproduct Matl." Paragraph re balance between adequate controls & avoidance of undue interference provided. (2 page(s), 4/15/1985)
• ML20137R349 - Concurs w/proposed rev to 10CFR35 w/condition that current general licensees not be affected or be notified of rulemaking & requested to indicate continued interest in maintaining general licensee status. (1 page(s), 8/30/1982)
• ML20137R989 - Comments on second draft of proposed rev to 10CFR35. Codifying universally accepted stds for safe use of radioactive matls supported.Objects to cessation of prelicensing review. (3 page(s), 11/10/1982)
• ML20137R792 - Responds to concerns in 840816 ltr that proposed rev to NRC medical regulations & licensing policy unacceptable. Not suggested that agency savings justify industry added burden. (3 page(s), 10/10/1984)
• ML20137R893 - Forwards revised matls insp program,effective 840720.IE & NMSS will use common program code sys for categorizing matls licensees.Category titles should be adopted to extent possible.IE Manual Chapter 2800 re matls insp program encl. (18 page(s), 8/8/1984)
• ML20137R368 - Opposes 820817 proposed rev to 10CFR35.Specific disagreements described in Paragraph 35.51 re calibr & check of safety instruments.Instruments should measure & be calibr up to 1,000 m/h,per Reg Guide 10.8. (2 page(s), 8/26/1982)
• ML20137Q959 - Comments on proposed rev to 10CFR35.Clarification requested re statement that membership of radiation safety committee must include authorized user for each type of use permitted. (4 page(s), 3/13/1984)
• ML20137R595 - Submits listed comments from Agreement States 830929 annual meeting.Need for guidance on recommended amounts for bonding for various categories of licensees identified.NRC requested to review position re AECL Theratron 80. (3 page(s), 10/5/1983)
• ML20137R949 - Comments supporting Agreement States concern re proposed rule 10CFR35.Common interests of NRC & Agreement States would be affected by proposed rev. (1 page(s), 3/15/1985)
• ML20137R815 - Responds to 841026 ltr re NRC proposal to revise 10CFR35 & associated licensing practices.Ltr also received from Mobley,representing Agreement States,requesting opportunity to address Commission on 10CFR35 proposal. (1 page(s), 12/4/1984)
• ML20137R540 - Provides position of Ofc of State Programs & of Agreement States re proposed rev to 10CFR35,per V Miller 841203 request.Ofc prepared to concur.Agreement States do not accept relaxed control. (2 page(s), 12/14/1984)
• ML20137S011 - Repts discovery of generic problem w/AECL Theratron 80 teletherapy device.Amend to NRC sealed source catalog recommended AECL should be ordered to take corrective action. (3 page(s), 7/7/1983)
• ML20137R555 - Advises that Agreement States expressed desire to present views re proposed rev to 10CFR35 to Commission,per Agreement States 841002-04 annual meeting in King of Prussia,PA.Written confirmation expected within 3 wks. (1 page(s), 10/15/1984)
• ML20137Q919 - Comments on second draft of proposed rule 10CFR35 re human use of byproduct matl.Termination of prelicensing review of radiation safety procedures will totally derail medical licensing program. (1 page(s), 10/20/1982)
• ML20137R574 - Responds to constituent inquiry re proposed revs to medical regulations,per 840518 request.BW Hammond comments will be taken under consideration during rev of mobile svcs section. (4 page(s), 6/11/1984)
• ML20137R356 - Forwards draft Commission paper re proposed rev to 10CFR35, "Human Use of Byproduct Matl," for approval & transmittal to EDO.Streamlined licensing procedure for medical applicants & value impact statement also encl.W/o encls. (2 page(s), 9/30/1982)
• ML20137Q932 - Forwards proposed rev to 10CFR35, "Medical Use of Byproduct Matl." Rev based on SECY-83-62 & Commission response. Proposed rule will not have significant environ impact.W/o encls. (2 page(s), 12/21/1984)
• ML20137R176 - Positive ballot re proposed rev of 10CFR35, "Medical Use of Byproduct Matl," (SECY-84-485).Comments on whether NRC should allow licensees to determine changes that require NRC approval should be solicited. (1 page(s), 5/6/1985)
• ML20137R147 - Submits progress rept on rev to 10CFR35,per 831220 request. Rev on schedule.First draft of regulation,preamble, Commission paper & Reg Guide 10.8 complete. (1 page(s), 1/6/1984)
• ML20137Q823 - Comments on draft 10CFR35 & draft rev to Reg Guide 10.8, per 840213 request.Definition of mgt for medical institutions need to be changed to allow flexibility. (6 page(s), 3/30/1984)
• ML20137R283 - Concurs w/820817 proposed rev to 10CFR35.Concerns re lack of stds for required procedures expressed. (1 page(s), 8/31/1982)
• ML20137Q612 - "Guide for Preparation of Applications for Medical Use of Radioisotopes." (67 page(s), 11/30/1965)
• ML20137Q734 - Forwards marked-up package of proposed revs to 10CFR35 & Reg Guide 10.8.Comment period of 90-120 days necessary to allow affected licensees to effectively analyze & respond to proposed rule.W/o encl. (3 page(s), 3/28/1984)
• ML20137R711 - Expresses gratitude for update on status of rev to 10CFR35.C Jupiter available as point of contact w/10CFR35 task force. (1 page(s), 9/6/1983)
• ML20137R603 - Forwards four Agreement State comments on rev to 10CFR35,per 830826 memo. (1 page(s), 11/4/1983)
• ML20137S018 - Clarifies recent ltr re revised criteria for training & experience for medical users of byproduct matl.Physician may submit application listing specific qualifications for NRC review & authorization to use radiopharms.FR notice encl. (13 page(s), 10/21/1976)
• ML20137R921 - Advises that Agreement States united in opinion that revs to licensing & insp procedures would be detrimental to existing regulatory programs,per A Godwin 850220 memo. Previous comments on proposed rev to 10CFR35 unchanged. (1 page(s), 2/20/1985)
• ML20137Q796 - Comments on draft 10CFR35 & Reg Guide 10.8,per 840213 request.Discrepancy exists between rule & NRC Form 313 re how licensees may modify procedures. (4 page(s), 3/30/1984)
• ML20137R328 - Submits progress rept on 10CFR35,per 831220 request.Package distributed for concurrence on 840713.Concurrences due on 840727. (1 page(s), 7/20/1984)
• ML20137R466 - Concurs in publication of proposed rev to 10CFR35 as written. (1 page(s), 7/31/1984)
• ML20137Q926 - Forwards comments on draft 10CFR35,per 831221 request. (4 page(s), 1/11/1984)
• ML20137R616 - Negative response sheet disapproving SECY-83-62 re proposed rev to 10CFR35, "Human Use of Byproduct Matl." Agrees w/staff requirements memo suggested by Ofc of Policy Evaluations 830613 memo. (1 page(s), 6/21/1983)
• ML20137Q697 - Comments on 820505 proposed rev to 10CFR35. "Human medical research" should be defined to include administration of byproduct matl or radiation from that to human beings for instructional purposes only.RC Hayes undated memo encl. (11 page(s), 6/24/1982)
• ML20137R632 - Response sheet requesting discussion re SECY-83-62 concerning proposed rev to 10CFR35, "Human Use of Byproduct Matl," w/NRC,Vacca,DelMedico & Agreement State representatives. (2 page(s), 3/8/1983)
• ML20137R784 - Responds to 830826 memo re rev to 10CFR35.L Bolling will serve as point of contact.Applicant should submit radiological safety plan containing procedural steps for complying w/NRC requirements. (1 page(s), 9/12/1983)
• ML20137Q882 - Comments on rev to 10CFR35 & Reg Guide 10.8.Retention of all records for insp cycle would permit verification of compliance for entire interval specified in regulation. (2 page(s), 4/2/1984)
• ML20137Q996 - Discusses work in progress re medical general license. Project will be discussed at Medical Advisory Committee 810831 meeting & at next Agreement State meeting. (1 page(s), 8/3/1981)
• ML20137R323 - Advises that proposed rev to 10CFR35 will be published in FR for public comment. "Source Documents for Rev of Part 35," dtd 830315,821126 "Analysis of Compliance Cost for Part 35" & related documentation encl. (19 page(s), 7/16/1985)
• ML20137R183 - Informs that author 830228 & 830302 memos,should be considered as direct communications of personal opinions per "open door policy" & Davis 811118 memo. (1 page(s), 3/8/1983)
• ML20137R491 - Concurs w/publication for public comment of proposed rev to 10CFR35,as specified in Alternative 3 on Page 5 of Commission paper,per 840713 memo.Three mods suggested in 840330 memo recommended for consideration. (3 page(s), 8/3/1984)
• ML20137R159 - Comments on proposed rev to 10CFR35 (SECY-83-62) re human use of byproduct matl.Deleting Box "a" from options for physician to indicate how training/experience requirements met would remove redundancy re board certification. (1 page(s), 6/17/1983)
• ML20137Q668 - Comments on rev to 10CFR35 & Reg Guide 10.8.Max permissible dose not mentioned.Isolation in private room necessary for brachytherapy patients.Patients w/Au-198 may require continuing hospitalization. (4 page(s), 5/1/1984)
• ML20137Q975 - Comments on proposed revs to 10CFR35 & Reg Guide 10.8. Only properly trained supervised individuals should be allowed expanded transportation exemption. (1 page(s), 3/22/1984)
• ML20137Q842 - Discusses impact of proposed rev to 10CFR35, "Human Use of Byproduct Matl," on 10CFR40.25 re general license for use of certain products or devices.Proposed 10CFR35.607 should be revised to state U shielding in teletherapy unit licensed. (2 page(s), 5/20/1982)
• ML20137R566 - Comments on revised proposed rule 10CFR35.Records retention provisions should be changed to require patient dosage records be retained indefinitely.Economic impact of changing practice re matl quantity spec cited. (4 page(s), 4/24/1984)
• ML20137R666 - Comments on proposed rev to 10CFR35,per NRC 830912 ltr. Approach offers only blanket radiation safety plan w/o ref to size of program.Inconsistency w/NUREG-0267 cited.No basis for more leniency for medical licensees. (2 page(s), 10/26/1983)
• ML20137Q791 - Discusses regulation & licensing of technologists in nuclear medicine,per proposed rev to 10CFR35.Choices available listed,including preclusion of unlicensed technologist from handling matl. (3 page(s), 9/16/1982)
• ML20137R044 - Expresses appreciation for opportunity to appear before Commission & give testimony re proposed changes to 10CFR35. W/KE Whately 830509 statement. (2 page(s), 4/22/1983)
• ML20137R169 - Concurs w/current version of proposed rev to 10CFR35,subj to listed reservations.Final draft substantial improvement over existing regulations. (1 page(s), 9/2/1982)
• ML20137R547 - Comments on latest version of proposed rev to 10CFR35 & Reg Guide 10.8.NRC should not relax licensing procedures. Mobile nuclear medicine licensees should be required to submit ltr of authorization from facilities serviced. (2 page(s), 4/11/1984)
• ML20137R065 - Forwards proposed rev to 10CFR35 re human uses of byproduct matls for comment or concurrence.Revs & actions proposed to simplify medical licensing process.Response requested by 820609.W/o encls. (1 page(s), 5/5/1982)
• ML20137Q644 - Comments on draft proposed rev to 10CFR35 to codify current suggestions on calibr of equipment,storage & measurements, per Reg Guide 10.8. (2 page(s), 3/4/1982)
• ML20137R227 - Submits progress rept on rev to 10CFR35,per 831220 request. Rev on schedule.Package distributed on 840213 to staff & Agreement States for comment re technical & policy matters. Comments due on 840330. (2 page(s), 4/11/1984)
• ML20137R654 - Ballot re "Human Uses of Byproduct Matls - Revs to 10CFR35," recommending mods. (1 page(s), 7/10/1984)
• ML20136F154 - Offers no legal objection to proposed rule 10CFR35 & accompanying matl. (1 page(s), 8/22/1984)
• ML20137Q557 - Marked-up draft rev to 10CFR35 re medical use of byproduct matl. (308 page(s), 2/13/1984)
• ML20137Q619 - "Guide for Preparation of Applications for Medical Use of Radioisotopes." (57 page(s), 4/30/1972)
• ML20137Q836 - Comments on proposed revs to 10CFR35 re human use of byproduct matl.Elimination of prelicensing review of radiation safety procedures of foremost concern.Marked-up summary of specific comments encl. (9 page(s), 10/7/1982)
• ML20137R731 - Responds to NRC 830912 ltr re concept proposed by Div of Fuel Cycle & Matl Safety to comply w/Commission 830419 directive on rev to 10CFR35.Directive not met.Continued prelicensing reviews required. (2 page(s), 10/20/1983)
• ML20137Q747 - Advises that exemption from 10CFR20.105 unnecessary in proposed rev to 10CFR35.Provision that limit intentional exposure of patients to radiation for medical diagnosis or treatment purposes noted in 10CFR20.107. (2 page(s), 7/13/1982)
• ML20137Q671 - Advises that AF Gibson designated to attend Task Force on Regulatory Improvement,per JG Davis 820308 memo.Review of draft rev to 10CFR35 completed.Suggestions will be forwarded. (1 page(s), 3/19/1982)
• ML20137Q686 - Responds to 820513 ltr on proposed rev to 10CFR35 re human use of byproduct matl.Decision to discontinue issuance of general licenses for human use prudent. (2 page(s), 6/16/1982)
• ML20136E323 - Advises that OELD has no legal objection to publication of proposed change to 10CFR35 subj to listed changes. (3 page(s), 9/28/1982)
• ML20137Q856 - Comments on draft proposed rule 10CFR35 re human use of byproduct matl.Complete documentation should be submitted w/application for license for review & approval by licensing agency. (2 page(s), 10/15/1982)
• ML20137R315 - Provides analysis of significance/impact of DelMedico & Vacca suggested changes to 10CFR35,per 830505 request.Rule rev,prelicensing review of physician qualifications,amend processing & prelicensing review of procedures discussed. (7 page(s), 6/13/1983)
• ML20137Q760 - Comments on proposed rev to 10CFR35.Waiver of all fees for license amends & renewals inconsistent w/intent of Commission fee policy.Assessment of fees must be fair. (2 page(s), 3/12/1984)
• ML20137Q526 - "Part 35 - Medical Use of Byproduct Matl." (12 page(s), 11/12/1981)
• ML20137R004 - Comments on draft 10CFR35.Paragraph requiring calibr dose rate of Co-60 from which monthly decay determination to be adjusted each yr inappropriate.Dose agreement w/previous full calibr value within 1% suggested. (2 page(s), 6/7/1982)
• ML20137R687 - Forwards comments on proposed rule 10CFR35,per NRC 830912 ltr.Concept does not meet Commission directive to continue prelicensing review of operating procedures. (3 page(s), 10/3/1983)
• ML20136E705 - Comments on rev to 10CFR35.Requests consideration of revised 10CFR20 re rev to 10CFR35 for current Section 20.303 exemption of patient excreta. (2 page(s), 1/10/1984)
• ML20137R906 - Comments on latest draft rev to 10CFR35 re description of Agreement States.Statements using word "minor" misconstrue true concerns. (2 page(s), 12/27/1984)
• ML20137Q633 - Comments on proposed rule 10CFR35.Reg Guide 10.8 should be abandoned.Proposed changes provide minimal assistance re what constitutes adequate program to comply w/regulations. (5 page(s), 3/3/1982)
• ML20137R251 - Positive ballot re SECY-84-485, "Proposed Rev of 10CFR35, `Medical Use of Byproduct Matl'." Comments encl. (2 page(s), 5/5/1985)
• ML20137R485 - Comments on proposed rev to 10CFR35 & Reg Guide 10.8. Implementation of greater flexibility under licensure not desirable approach to regulation.Turnover of personnel at human use facilities does not allow continuity. (7 page(s), 3/23/1984)
• ML20137Q719 - Incorporates comments from Region I Matls Radiological Protection Section & Licensing Section re draft rev to 10CFR35 on qualifications of physicians using licensed matl. Physician qualifications not regarded. (5 page(s), 3/22/1985)
• ML20137S003 - Responds to constituent inquiry re proposed revs to 10CFR35, per 840518 request.BW Hammond comments will be taken under consideration during rev of mobile svcs section. (1 page(s), 6/11/1984)
• ML20137R258 - Comments on proposed rev to 10CFR35 re human use of byproduct matl.Early insp essential if preevaluation of equipment & procedures eliminated.Agreement States negative opinion expected.Addl comments encl. (3 page(s), 6/14/1982)
• ML20137Q742 - Forwards marked-up N McElroy 820226 draft rev to 10CFR35. Changes provide advantage of objectivity.Review guided by considerations of legal proprietary. (1 page(s), 3/26/1982)
• ML20137R761 - Summary of 850110 briefing on 10CFR35.Briefing for Draggitis scheduled for 850125.FR Notice 44FR842 re regulation of medical uses of radioisotopes statement of general policy & 10CFR35 encl. (13 page(s), 1/18/1985)
• ML20136E266 - Expresses concern that proposed revision of 10CFR35 periodic & systematic review & value/impact analysis recognizes no relationship to other existing regulations. Detailed comments listed. (2 page(s), 5/20/1982)
• ML20137Q863 - Comments on draft proposed rev to 10CFR35 re human uses of byproduct matls.NRC review of ALARA program, misadministration reporting & collection of trapping of Xe-133 should be clarified.HEW updated draft ltr encl. (6 page(s), 5/28/1982)
• ML20137R673 - Positive ballot re "Human Uses of Byproduct Matls - Revs to 10CFR35." (1 page(s), 7/5/1984)
• ML20137Q690 - Responds to 820308 memo re regulatory improvement in matl licensing.G Roy assigned as representative to task force. (1 page(s), 3/12/1982)
• ML20137R303 - Submits progress rept on 10CFR35,per 831220 request. Comments due on 840330 not received from OELD until 840507 & from RES until 840510.Number of comments greater than anticipated. (1 page(s), 6/14/1984)
• ML20137R525 - Responds to 840329 ltr re draft rev to 10CFR35.Every question,comment & concern given careful consideration, regardless of origin. (1 page(s), 4/10/1984)
• ML20137R247 - Submits progress rept on rev to 10CFR35,per 831220 request. Package distributed on 840213 w/comments due on 840330.Two NRC ofcs did not submit comments.Comments resolution phase taking longer than anticipated. (1 page(s), 5/9/1984)
• ML20137Q909 - Comments on proposed rev to 10CFR35 re human uses of byproduct matls.Consolidation of 10CFR35 & Reg Guide 10.8 necessary.Changes in licensing procedure inappropriate. (2 page(s), 10/18/1982)
• ML20137R560 - Comments on proposed rev to 10CFR35 & Reg Guide 10.8.Rules place undue burden for license review procedures upon compliance personnel.Low range survey meters used in hosps cannot detect amount of radioactivity required. (2 page(s), 4/23/1984)
• ML20137R038 - Requests briefing during wk of 811214 re expansion of general license concept in area of medical licensing. Schedule w/milestones & products requested.Sandia study interrelation w/general license study should be emphasized. (1 page(s), 12/3/1981)
• ML20137R272 - Advises that Commission approved SECY-84-485, "Proposed Rev of 10CFR35, `Medical Use of Byproduct Matl'," subj to listed mods. (3 page(s), 6/14/1985)
• ML20137R581 - Comments on radiological safety plan & area survey procedures,per proposed rev to 10CFR35.Rev to example of area survey plan suggested,listing required elements for written procedures. (3 page(s), 8/24/1983)
• ML20137R025 - Comments on draft proposed rev to 10CFR35 re human uses of byproduct matls.Definitions of "dose", "sealed source" & "average radiation levels at 1 meter" should be clarified. (3 page(s), 6/9/1982)
• ML20137R111 - "Analysis of Part 35 License Amends." Handwritten notes encl. (13 page(s), 3/25/1985)
• ML20137R152 - Comments on proposed rule 10CFR35,per 820817 memo.Rule should include provision to alleviate unnecessary case-by-case filing of Form NRC-483 for in vitro use of byproduct matl. (1 page(s), 9/24/1982)
• ML20136E272 - Reviews proposed rev to 10CFR35 re radiation protection requirements.Supports rev. (3 page(s), 6/10/1982)
• ML20137R234 - Rept to Congress: "Mgt of Licensing of Users of Radioactive Matls Should be Improved." (43 page(s), 2/11/1976)
• ML20137R852 - Notifies that RD Thomas will serve as Region V representative on 10CFR35 task force & be point of contact for 10CFR35 draft reviews,per 830826 request. (1 page(s), 9/6/1983)
• ML20137Q777 - Comments on draft rev to 10CFR35 & Reg Guide 10.8 re medical use of radioisotopes.Rule awkward because of need to distinguish between radiation safety officer & radiation safety committee.Marked-up rev encl. (31 page(s), 5/10/1984)
• ML20137R265 - Responds to 830419 request for mark-up of staff proposal, per briefing on SECY-83-62.Mark-up & list of addl items that should be resolved before publication encl.Xe-133 requires special ventilation,equipment & procedures. (107 page(s), 4/26/1983)
• ML20137R646 - Informs of personnel resource problem re completion of work on 10CFR35.Revised package can be completed by 831201 w/ adequate staff.Help in resolving problem requested. (2 page(s), 8/17/1983)
• ML20137R828 - Notifies that P Chambless will be Region II representative on task force revising 10CFR35,per 830826 memo. (1 page(s), 9/9/1983)
• ML20137R513 - Comments on 840208 draft proposed changes to 10CFR35. Consideration of Agreement State experience & knowledge of state radiation programs prior to implementation imperative,as Agreement States issue 66% matl licenses. (2 page(s), 3/29/1984)
• ML20137R410 - Forwards K Whatley & ML Blazek comments on 840208 version of proposed rev to 10CFR35.Statement that Agreement States participated in development of changes erroneous & misleading. (12 page(s), 3/23/1984)
• ML20136E492 - Forwards legal analysis on licensing of medical institutions & physicians under 10CFR35.11 & 10CFR35.12.Commission cannot deny license application merely because applicant does not operate hosp. (10 page(s), 4/29/1983)
• ML20137R388 - Concurs w/proposed rev to 10CFR35.Marked-up draft package encl,containing comments & editorial corrections.W/o encl. (1 page(s), 6/9/1982)
• ML20137Q566 - Package of viewgraphs re proposed rev to 10CFR35. (34 page(s), 9/6/1985)
• ML20137Q729 - Comments on proposed rev to 10CFR35 re use of medical radiopharms in non-Agreement States & territories.Concurs w/incorporation of requirements currently placed on licensees by license conditions. (6 page(s), 7/8/1982)
• ML20137R278 - Requests authorization to change 10CFR35 schedule due to OELD & RES late submittal of comments receipt of greater vol than expected & time spent on related issue re training & experience stds raised by group of physicians. (2 page(s), 6/14/1984)
• ML20137R289 - Requests FR publication of encl proposed rev to 10CFR35. Public comments should be received within 120 days after publication.Encl congressional ltrs,public announcement & FR notice should be mailed.W/o encls. (1 page(s), 7/10/1985)
• ML20137R694 - Discusses status of rev to 10CFR35.Agreement States believe applicant procedures & training & experience of authorized users should be reviewed before license issued to ensure safety of procedures.Proposed procedures encl. (10 page(s), 8/26/1983)
• ML20137R640 - Responds to 830912 request for comments on rev to medical licensing procedures.NRC radiation safety plan concept does not comply w/Commission directive to continue prelicensing review of operating procedures. (1 page(s), 10/4/1983)
• ML20137R943 - Comments on proposed rule 10CFR35,per 850114 notice to all Agreement States.Operating procedures for licensees should not be changed. (2 page(s), 3/11/1985)
• ML20137R505 - Advises that clarification of Region III position re proposed rev to 10CFR35 received.Minor mod to text required prior to forwarding to EDO. (1 page(s), 11/15/1984)
• ML20136E318 - Proposes changes to draft Commission paper, "Proposed Rev of 10CFR35 of Human Use of Byproduct Matl." (2 page(s), 8/30/1982)
• ML20137R887 - Forwards breakdown of resources required to accomplish assigned & anticipated work in medical & academic licensing section through 1983.Resources insufficient. (4 page(s), 8/30/1983)
• ML20137R956 - Comments on proposed amend to 10CFR35 re adoption of new review & insp procedures for nuclear medicine licensees. Changes unnecessary.Reduction in license review stage effort only gain. (1 page(s), 3/18/1985)
• ML20137R868 - Suggests NRC Std Condition 70 be revised to state acceptability of averaging dose rate over 100 square cm area,per NCRP Rept 33,Section 4.2.2. (2 page(s), 8/24/1983)
• ML20137R588 - Requests analysis of significance & impact of DelMedico & Vacca suggested changes to proposed rule 10CFR35 (SECY-83-62). (1 page(s), 5/5/1983)
• ML20137R032 - Forwards marked-up draft rev to 10CFR35.Rev significant improvement to current regulations governing medical licensing. (1 page(s), 6/9/1982)
• ML20137R364 - Requests authorization to change 10CFR35 schedule due to time required to resolve OELD comments.Concurrences should be received & OELD comments resolved by 840817.Comments requiring clarification should be incorporated by 840824. (1 page(s), 8/15/1984)
• ML20137Q870 - Forwards Conference of Radiation Control Program Directors, Inc 821007 comments on 820831 rev to 10CFR35.Discussion of concerns requested in Commission paper.Handwritten discussion of comments also encl. (1 page(s), 10/18/1982)
• ML20137R139 - Approves info collection entitled, "10CFR35 - Medical Use of Byproduct Matl," through 880531.NRC supporting statement encl. (2 page(s), 5/15/1985)
• ML20137R072 - Forwards draft plan for revising 10CFR35.Regulation,preamble & Reg Guide 10.8 will be distributed for review on 840228. Comments due on 840430.Package will be forwarded to NMSS for transmittal to EDO 840630. (8 page(s), 11/21/1983)
• ML20137Q721 - Comments on proposed rev to 10CFR35.Draft rewrite of first part of rule & proposed App A encl.App A provide general requirements for radiation safety program for institutional license.Reg guide for std format & content needed. (20 page(s), 6/30/1982)
• ML20137R102 - Comments on proposed changes to 10CFR35.Commission version of proposed rule not provided to Agreement States.Value/ impact statement erroneously cites Agreement State support. (5 page(s), 5/25/1983)
• ML20137Q965 - Comments on proposed rev to 10CFR35.Confusion re number of revs & guides on Part 35 cited.Master plan would be helpful. American Board of Radiology in Physics should be included in 10CFR35.900. (2 page(s), 6/7/1982)
• ML20136E879 - Submits comments on proposed rev to 10CFR35 & Reg Guide 10.8 re preparation of applications for medical programs & requests addl info for review. (2 page(s), 3/21/1984)
• ML20137R012 - Comments on proposed rev to 10CFR35 re human uses of byproduct matls.Issuance of general license or registration which NRC does not inspect questioned.Increasing exempt quantities for specific uses supported. (3 page(s), 6/9/1982)
• ML20137R219 - Discusses review of proposed rev to 10CFR35 re human use of byproduct matl.Concerns of Agreement States not addressed in body of paper.Cost analysis of rev effect on matl insp program not addressed.Addl comments encl. (3 page(s), 8/31/1982)
• ML20137R937 - Marked-up memo re rev to std review plan for institution operating as mobile van.Limitations of types of svcs listed, per Medical Licensing Section 811120 workshop.Info to be submitted for mobile license listed in encl. (2 page(s), 12/11/1981)
• ML20137R932 - Comments on proposed rule 10CFR35,per 850114 memo to all Agreement States.Changes allowing licensee to revise radiation safety program w/o prior approval of licensing agency opposed. (2 page(s), 2/28/1985)
• ML20137R876 - Notifies that B Mallett appointed as member of task force revising 10CFR35,per 830826 memo & 830919 telcon. (1 page(s), 11/25/1983)
• ML20136E295 - Forwards comments on proposed rev to 10CFR35 re medical licensing. (5 page(s), 9/1/1982)
• ML20137R310 - Comments on proposed rev to 10CFR35,per 820817 memo.Concern expressed re not calibr GM-type survey instruments after initial calibr & servicing.Inconsistency w/Reg Guide 10.8 & 10CFR34.24 cited. (1 page(s), 8/30/1982)
• ML20137R926 - Marked-up memo re situations in transfer of radioactive matls between NRC-licensed medical institutions that do not require transfer to obtain distribution license. (3 page(s), 12/11/1981)
• ML20137Q605 - Forwards revised criteria for training & experience for medical users of byproduct matl.Policy effective immediately w/o effect on physicians already authorized as users on medical license. (6 page(s), 9/6/1985)
• ML20137Q754 - Comments on behalf of New England Chapter of AAPM on draft 10CFR35 re licensing & use of radioactive matls in medical facilities.Definition of licensee should be included. (5 page(s), 4/12/1982)
• ML20137Q948 - Comments on official draft or proposed rev to 10CFR35. Proposed Reg Guide 10.8 for medical programs should require "equivalent" procedures to be documented in license applications. (6 page(s), 6/4/1982)
• ML20137Q628 - Ack receipt of 820121 ltr re actions taken in response to American Assoc of Physicists in Medicine petition to amend Paragraphs 35.23(a) & 35.25(a) of 10CFR35. (1 page(s), 2/8/1982)
• ML20137Q942 - "Efficacy of Various Syringe Shields for Tc-99m." (8 page(s), 1/19/1981)
• ML20137R382 - Forwards draft FR notice of reg guide re rev to regulations governing human use of byproduct matl,for review & comment. W/o encls. (1 page(s), 2/14/1984)
• ML20137Q710 - Informs that H Book desgnated as representative to Task Force on Regulatory Improvement in Matl Licensing,per JG Davis 820308 memo. (1 page(s), 3/19/1982)
• ML20137R846 - Notifies that GD Brown will represent Region IV on 10CFR35 task force,per 830826 memo. (1 page(s), 9/15/1983)
• ML20137R880 - Responds to comments & recommendations developed by states at 1984 Agreement States meeting,per Mobley 841025 ltr. Summary of states views will be contained in any proposal submitted to Commission for decision. (6 page(s), 12/4/1984)
• ML20137Q639 - Comments on draft proposed rev to 10CFR35 re human use of byproduct matl.Procedures written by licensee should be submitted for NRC review.Increase in required training & experience for physicans supported. (2 page(s), 6/8/1985)
• ML20137R756 - Response sheet requesting discussion re SECY-83-62 concerning proposed rev to 10CFF35, "Human Use of Byproduct Matl," per Ahearne comments. (1 page(s), 3/15/1983)
• ML20137R680 - Positive ballot re "Human Uses of Byproduct Matls - Revs to 10CFR35." (1 page(s), 7/14/1984)
• ML20137R723 - Offers no comments on rev to 10CFR35,per 830826 memo. H Karagiannis will be IE contact w/task force members revising 10CFR35. (2 page(s), 9/9/1983)
• ML20137Q724 - Comments on proposed rule 10CFR35 & draft rev to Reg Guide 10.8.Conflicting statements re use of general license & question on assurance of physician training adequacy cited. Addl comments encl. (4 page(s), 3/13/1984)
• ML20137Q809 - Comments on draft proposed rule 10CFR35 re human use of byproduct matl.Objects to lack of application documentation for applicant program.Documentation should be submitted for review w/application for license. (11 page(s), 9/22/1982)
• ML20137R444 - Concurs w/proposed rev to 10CFR35,subj to listed comments re definition of term "confinement," bioassays after I-131 administration & typos. (1 page(s), 7/27/1984)
• ML20137R452 - Concurs w/proposed rev to 10CFR35.Marked-up package encl. Incorporation by ref of cited procedures must be approved by Ofc of FR.Request for approval should be submitted 20 days before publication of final rule. (1 page(s), 7/27/1984)
• ML20137Q771 - Comments on 10CFR35.Word "output" synonymous w/exposure or dose rate.General working would make regulations more self-consistent. (2 page(s), 4/19/1982)
• ML20137R659 - Positive ballot re "Human Uses of Byproduct Matls - Revs to 10CFR35." (1 page(s), 6/28/1984)
• ML20137R019 - Responds to Commission 850320 request for characterization of licensee requests for license amends.Number of beds in hosp does not provide valid basis for distinguishing regulatory treatment of medical licensees. (3 page(s), 4/3/1985)
• ML20137R134 - Forwards Commission instruction & staff plan for responding to instructions to change proposed rev to 10CFR35 & Reg Guide 10.8.Regulation,preamble & Reg Guide 10.8 will be distributed for review of 840228.W/o encl. (2 page(s), 12/6/1983)
• ML20137R437 - Staff requirements memo on Commission 830419 briefing in Washington,DC re SECY-83-62 concerning proposed rev to 10CFR35, "Human Use of Byproduct Matl." Guidance on proposed rev by notation votes requested. (1 page(s), 4/19/1983)
• ML20137R997 - Comments on proposed rev to 10CFR35 re medical use of byproduct matl,per SECY-84-485 & SECY-83-62.Suggested issues for discussion at Part 34 meeting & issues which might be discussed separately listed. (5 page(s), 3/11/1985)
• ML20137R203 - Positive ballot re SECY-84-485, "Proposed Rev of 10CFR35, `Medical Use of Byproduct Matl'," as modified. (1 page(s), 4/29/1985)
• ML20137R423 - Comments on document forwarded by RE Cunningham 840713 ltr. Changes clarify use of reactor produced radioactive matls in medical use & provide expansion in areas of increased use. (1 page(s), 7/27/1984)
• ML20137Q726 - Comments on draft 10CFR35 re human use of byproduct matl. Min hours of training should be used in all instances where approx hours used. (2 page(s), 3/22/1982)
• ML20137R821 - Forwards revised up-to-date list of matl licensing std conditions w/explanation.List dtd Dec 1981 should be discarded.Std conditions should be used to max extent possible. (5 page(s), 10/20/1983)
• ML20136F099 - Forwards rulemaking review package re human uses of byproduct matl & 840530 procedures for conducting review.W/o encls. (2 page(s), 6/8/1984)
• ML20137R299 - Discusses proposed rule 10CFR35.Design stds critical to any licensee plan to meet ideal performance std selected by drafting committee.Under current rule,licensing role evolved into enforcement tool.Handwritten notes encl. (3 page(s), 4/14/1983)
• ML20137Q705 - Comments on proposed rule 10CFR35 & Reg Guide 10.8.Assurance of training adequacy must be provided.Revs to other NRC regulations allowing nonaccredited instruction might be considered separately. (2 page(s), 3/19/1984)
• ML20137Q804 - Comments on proposed rev to 10CFR35 & Reg Guide 10.8,per 840213 request.Guidance will be necessary on what actions license reviewer must take if procedures do not meet regulatory requirements. (3 page(s), 4/6/1984)
• ML20137R532 - Comments on proposed rev to 10CFR35.Transfer of licensing judgement to applicant will not reduce faults in understanding & reasoning which exist currently.Inspector should not bear responsibility for reviewing procedures. (1 page(s), 4/19/1984)
• ML20137R125 - Forwards W Spell 830422 & KE Whately 830509 ltrs re Agreement States comments on proposed rev to 10CFR35. (1 page(s), 6/3/1983)
• ML20137R088 - Comments on proposed rule 10CFR35 re licensure for human use of byproduct matl,per review of testimony at 830419 hearing in Washington,DC.Rule represents major improvement over currently existing regulations. (2 page(s), 5/11/1983)
• ML20137Q766 - Concurs w/proposed rev to 10CFR35,subj to listed comments. Value/impact statement should indicate cost to licensee of any info collection requirements imposed for first time by regulation. (1 page(s), 8/31/1982)
• ML20137Q830 - Comments on proposed rev to 10CFR35,per 831214 request. Allowing radiation safety officer or radiation safety committee to review & approve modified procedures could cause some health & safety problems. (7 page(s), 1/11/1984)
• ML20137Q538 - Marked-up draft proposed rules 10CFR30,31,32,35,40 & 71 re human uses of byproduct matl. (109 page(s), 8/18/1983)
• ML20137R051 - Advises of major effort in progress to make matls licensing process more efficient through regulatory improvement. Regional participation encouraged.Key individual from each region should be identified as representative to task force. (3 page(s), 3/8/1982)
• ML20137R964 - Comments on proposed rule 10CFR35.Draft contains statements which do not ensure adequate protection from radiation. (2 page(s), 3/20/1985)
• ML20137R189 - Submits progress rept on rev to 10CFR35,per 831220 request. Rev on schedule.Listed drafts distributed for comment on 840213.Comment period closes on 840330. (1 page(s), 3/8/1984)
• ML20137Q850 - Proposes list of info to be obtained from applicants & used as basis for reviewing adequacy of radiation safety officer for licenses of broad scope. (6 page(s), 10/31/1983)
• ML20137R163 - Submits progress rept on rev to 10CFR35,per 831220 request. Rev on schedule.Regulation,preamble & reg guide will be distributed for review on 840210. (1 page(s), 2/7/1984)
• ML20137R007 - Comments on proposed changes to 10CFR35.Backlog of license applications & requests for renewal/amend to licenses not logical reason for changing regulation.Health & safety should be sole concern of regulatory agency. (3 page(s), 6/8/1982)
• ML20137Q695 - Advises that GD Brown will attend Task Force on Regulatory Improvement in Matl Licensing 820325 meeting,per JG Davis 820317 memo.Comments re 820226 draft rev to 10CFR35 forwarded to W Walker. (1 page(s), 3/17/1982)
• ML20137R417 - Requests concurrence w/proposed rev to 10CFR35 w/listed changes,by 840727. (7 page(s), 7/13/1984)
• ML20137Q688 - Comments on proposed rev to 10CFR35, "Human Uses of Byproduct Matls." Consolidation of criteria used in review of licenses,amends & renewal supported.Shift of burden from NRC licensing to insp staff of concern. (4 page(s), 6/17/1982)
• ML20137Q676 - Comments on proposed rev to 10CFR35 re human use of byproduct matl.Agreement State programs devoted to individual licensing action & timely onsite insp far superior in achieving legitimate health & safety program. (2 page(s), 6/10/1982)
• ML20137Q545 - Marked-up draft proposed rules 10CFR30,31,32,35,40 & 71 re human uses of byproduct matl. (110 page(s), 12/7/1983)
• ML20137Q531 - Draft 10CFR35 re human use of byproduct matl.Marked-up draft also encl. (384 page(s), 1/12/1982)
• ML20137R777 - Forwards text for memo to commissioner assistants for forwarding breakdown chart re SECY-83-62,concerning proposed rev to 10CFF35, "Human Use of Byproduct Matl." (7 page(s), 4/11/1983)